Pharmteco

Bio & Pharma SK Pharmteco bags obesity treatment deal worth up to $1.4 bn

SK Pharmteco Co., a contract development and manufacturing organization (CDMO), has secured an obesity treatment order worth up to 2 trillion won ($...

Bio & Pharma Samsung Biologics wins $668 million CDMO deal with European pharma

Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it has signed two drug manufacturing contracts worth a combin...

Bio & Pharma SK Pharmteco to invest $260 mn in new peptide factory in S. Korea

SK Pharmteco, the contract development and manufacturing organization (CDMO) of South Korea's SK Inc., said on Tuesday that it plans to invest $260 ...

Corporate restructuring SK Inc. in talks to sell Pharmteco’s US CDMO plant to Novo Nordisk

SK Inc., the holding and investment company of SK Group, South Korea’s second-largest conglomerate, is negotiating to sell a major asset of it...

Bio & Pharma SK Pharmteco launches new viral vector platforms, key for CGT

SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), has recently introduced two...

Bio & Pharma SK Pharmteco gears up for big leap in advanced biotherapies

SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), is upping the ante in its b...

Bio & Pharma SK Pharmteco secures 12 global pharma clients, sets up US R&D center

SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), has secured 12 global pharm...

Pre-IPOs SK Pharmteco to raise $500 mn in pre-IPO, aims for 2025 listing

SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), is set to raise $500 millio...

Bio & Pharma SK Pharmteco opens 2nd biomanufacturing plant in France

SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), has secured a second plant ...

Pre-IPOs SK Pharmteco again seeks $382 mn in pre-IPO funding

SK Pharmteco Co., a contract development and manufacturing organization (CDMO), is eyeing pre-initial public offering funding again after it dropped...

Pre-IPOs SK Pharmteco to raise up to $498 mn on $5 bn valuation

SK Pharmteco, a contract development and manufacturing organization (CDMO) for pharmaceuticals, is slated to raise 400 billion ($332.2 million) to 6...